Prospects in Chinese biologics market attract global company

June 13, 2013 | Analyst Insight

Last week, Boehringer Ingelheim, a German pharmaceutical company, announced that it had signed an agreement with Zhangjiang Biotech & Pharmaceutical Base Development to build a cGMP biologics manufacturing facility...